Cord blood lipid profile in a population of Iranian term newborns

Zohreh Badiee1, Roya Kelishadi

  • 1Division of Neonatology, Department of Pediatrics, Isfahan University of Medical Sciences, Isfahan, Iran. badiei@med.mui.ac.ir

Pediatric Cardiology
|November 30, 2007
PubMed

Insights

Iranian newborns exhibit elevated serum lipoprotein a (LPa) and triglyceride (TG) levels, indicating a potential increased risk for premature coronary artery disease (CAD). Further longitudinal studies are needed to assess this risk.

Area of Science:

  • Neonatal screening
  • Cardiovascular disease risk factors
  • Lipid metabolism

Background:

  • Premature coronary artery disease (CAD) and its risk factors are prevalent in Iran.
  • Atherosclerosis development begins in childhood, with origins potentially traceable to birth.
  • Assessing neonatal serum lipid levels is crucial for early risk identification.

Purpose of the Study:

  • To measure serum lipoprotein and apolipoprotein levels in a representative sample of Iranian newborns.
  • To identify potential early indicators of cardiovascular risk in the neonatal population.

Main Methods:

  • Analysis of cord blood lipid profiles, apolipoprotein A, apolipoprotein B, and lipoprotein a (LPa) in 378 full-term Iranian neonates.
  • Comparison of biochemical factors between male and female neonates.

Main Results:

  • Female neonates showed significantly higher concentrations of total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C) compared to males.
  • Mean and median serum LPa concentrations were approximately five times higher than reported in other studies.
  • Triglyceride (TG) concentrations were 1.5-2 times higher than previously reported values.

Conclusions:

  • Iranian neonates exhibit significantly higher serum LPa and TG concentrations than previously documented.
  • These elevated levels may place the Iranian population at increased risk for future CAD.
  • Longitudinal studies are recommended to further investigate and confirm these findings and their implications for cardiovascular health.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure: